BackgroundSocial communication impairments following acquired brain injury (ABI) are welldocumented. There is evidence that group interventions are beneficial but research into validated instruments to measure group outcomes is a new field of investigation. Aims This study reports on the inter-rater reliability of three established social communication measures for use with group interaction data: the Profile of Pragmatic Impairment in Communication (PPIC), the Behaviorally Referenced Rating System of Intermediate Social Skills (BRISS-R), the Adapted Measure of Participation in Conversation (MPC). Inter-rater reliability of the Interactional Network Tool (INT), a new digital tool designed for group interactional behaviours, is also evaluated.
MethodThirty one video samples of ABI group interactions were independently rated by two rater pairs using the four outcome measures. Inter-rater reliability was calculated using intra-class correlations (ICC).
ResultsICC estimates and their 95% confidence intervals were calculated for the different measures. The measures showed differential sensitivity. Rater agreement on the MPC interaction (ICC=0.77) and transaction (ICC=0.74) scales was moderate to good. The INT initiation frequencies (ICC=0.83) were moderate to excellent and the INT response frequencies (ICC=0.69) were poor to good. Poor to moderate reliability was achieved on the BRISS-R PCSS (ICC=0.49) and PDBS (ICC=0.50) scale and PPIC findings were moderate but showed presence of skew.
Conclusion
Acceptable reliability was achieved on two measures of participation (MPC and INT).The INT shows promise as a new method to characterise interactions and detect change in group communication behaviour.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.